Exacerbations and Eosinophil Levels in ACCESS Cohort Participants Prescribed Inhaled Triple Therapy

H. Müllerová (Uxbridge, United Kingdom), C. El-Baou (Uxbridge, United Kingdom), D. Galkin (Research Triangle Park, United States of America), P. Jones (Brentford, United Kingdom)

Source: International Congress 2018 – Innovative therapies in asthma and COPD
Session: Innovative therapies in asthma and COPD
Session type: Poster Discussion
Number: 614
Disease area: Airway diseases

Congress or journal article abstractSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Müllerová (Uxbridge, United Kingdom), C. El-Baou (Uxbridge, United Kingdom), D. Galkin (Research Triangle Park, United States of America), P. Jones (Brentford, United Kingdom). Exacerbations and Eosinophil Levels in ACCESS Cohort Participants Prescribed Inhaled Triple Therapy. 614

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: